ClinicalTrials.gov
public full text
Public Domain
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
1. To evaluate the efficacy of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker 2. To evaluate the safety of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CER-001 Atherosclerosis Regression ACS Trial#1008026
- Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina#1044787
- Analysis of antiphospholipid antibodies and cystatin C in multiple sclerosis patients [Análisis de anticuerpos antifosfolipídicos y cistatina C en pacientes con esclerosis múltiple]#948798
- Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics#848340
- A Hybrid Hierarchical Framework for Quantifying Mechanical Markers in Atherosclerotic Disease Progression: A New Approach for Diagnosis and Risk Assessment.#1158745
Record · ID 1162606
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive